Industry Research Reports
Home > Reports > Medical Care > Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Medical Care
Published Date: 2025-09-08
Pages: 110 Pages
Report ld: 4681136
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Stem Cell Therapy Market Size(US$)
CAGR 2025-2031
19.7%
Market Size,2031
USD 2,373
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 807 million
Market Forecast in 2031(Value)
US$ 2,373 million
CAGR
19.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Stem Cell Therapy market size was US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.
The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson’s disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).
The global Stem Cell Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Medipost
- Theracell Advanced Biotechnology
- Nature Cell
- Stempeutics
- Regeneus
- Bluebird bio, Inc
- NIPRO
- Kyowa Kirin
- CorestemChemon Inc.
- ANTEROGEN.CO., LTD.
- Holostem
- NuVasive
- JCR Pharmaceutical
- Pharmicell
- Medi-post
- Anterogen
- Takeda (TiGenix)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Allogeneic Stem Cell Therapies
- Autologous Stem Cell Therapies
Segment by Application
- Neurodegenerative Diseases
- Cardiovascular Disorders
- Autoimmune Conditions
- Orthopedic Injuries
- Cancer
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Stem Cell Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Autologous Stem Cell Therapies in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiovascular Disorders in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Stem Cell Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Allogeneic Stem Cell Therapies
1.2.3 Autologous Stem Cell Therapies
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Disorders
1.3.4 Autoimmune Conditions
1.3.5 Orthopedic Injuries
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Stem Cell Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Stem Cell Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.3 China Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.4 Japan Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.6 India Stem Cell Therapy Market Size and Prospective (2020-2031)
2.5.7 Central & South America Stem Cell Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Stem Cell Therapy Historic Market Size by Type (2020-2025)
3.2 Global Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Stem Cell Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Stem Cell Therapy Historic Market Size by Application (2020-2025)
4.2 Global Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Stem Cell Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Stem Cell Therapy Players by Revenue (2020-2025)
5.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Stem Cell Therapy Revenue
5.4 Global Stem Cell Therapy Market Concentration Analysis
5.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2024
5.5 Global Key Players of Stem Cell Therapy Head office and Area Served
5.6 Global Key Players of Stem Cell Therapy, Product and Application
5.7 Global Key Players of Stem Cell Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Stem Cell Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Stem Cell Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Stem Cell Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Stem Cell Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Stem Cell Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Stem Cell Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Stem Cell Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Stem Cell Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Stem Cell Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Stem Cell Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Stem Cell Therapy Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Stem Cell Therapy Market Size by Type (2020-2025)
6.3.2.2 China Stem Cell Therapy Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Stem Cell Therapy Market Size by Application (2020-2025)
6.3.3.2 China Stem Cell Therapy Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Stem Cell Therapy Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Stem Cell Therapy Market Size by Type (2020-2025)
6.4.2.2 Japan Stem Cell Therapy Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Stem Cell Therapy Market Size by Application (2020-2025)
6.4.3.2 Japan Stem Cell Therapy Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Stem Cell Therapy Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Stem Cell Therapy Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Stem Cell Therapy Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Stem Cell Therapy Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Stem Cell Therapy Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Stem Cell Therapy Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Stem Cell Therapy Market Size by Type (2020-2025)
6.6.2.2 India Stem Cell Therapy Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Stem Cell Therapy Market Size by Application (2020-2025)
6.6.3.2 India Stem Cell Therapy Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Medipost
7.1.1 Medipost Company Details
7.1.2 Medipost Business Overview
7.1.3 Medipost Stem Cell Therapy Introduction
7.1.4 Medipost Revenue in Stem Cell Therapy Business (2020-2025)
7.1.5 Medipost Recent Development
7.2 Theracell Advanced Biotechnology
7.2.1 Theracell Advanced Biotechnology Company Details
7.2.2 Theracell Advanced Biotechnology Business Overview
7.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Introduction
7.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2020-2025)
7.2.5 Theracell Advanced Biotechnology Recent Development
7.3 Nature Cell
7.3.1 Nature Cell Company Details
7.3.2 Nature Cell Business Overview
7.3.3 Nature Cell Stem Cell Therapy Introduction
7.3.4 Nature Cell Revenue in Stem Cell Therapy Business (2020-2025)
7.3.5 Nature Cell Recent Development
7.4 Stempeutics
7.4.1 Stempeutics Company Details
7.4.2 Stempeutics Business Overview
7.4.3 Stempeutics Stem Cell Therapy Introduction
7.4.4 Stempeutics Revenue in Stem Cell Therapy Business (2020-2025)
7.4.5 Stempeutics Recent Development
7.5 Regeneus
7.5.1 Regeneus Company Details
7.5.2 Regeneus Business Overview
7.5.3 Regeneus Stem Cell Therapy Introduction
7.5.4 Regeneus Revenue in Stem Cell Therapy Business (2020-2025)
7.5.5 Regeneus Recent Development
7.6 Bluebird bio, Inc
7.6.1 Bluebird bio, Inc Company Details
7.6.2 Bluebird bio, Inc Business Overview
7.6.3 Bluebird bio, Inc Stem Cell Therapy Introduction
7.6.4 Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2020-2025)
7.6.5 Bluebird bio, Inc Recent Development
7.7 NIPRO
7.7.1 NIPRO Company Details
7.7.2 NIPRO Business Overview
7.7.3 NIPRO Stem Cell Therapy Introduction
7.7.4 NIPRO Revenue in Stem Cell Therapy Business (2020-2025)
7.7.5 NIPRO Recent Development
7.8 Kyowa Kirin
7.8.1 Kyowa Kirin Company Details
7.8.2 Kyowa Kirin Business Overview
7.8.3 Kyowa Kirin Stem Cell Therapy Introduction
7.8.4 Kyowa Kirin Revenue in Stem Cell Therapy Business (2020-2025)
7.8.5 Kyowa Kirin Recent Development
7.9 CorestemChemon Inc.
7.9.1 CorestemChemon Inc. Company Details
7.9.2 CorestemChemon Inc. Business Overview
7.9.3 CorestemChemon Inc. Stem Cell Therapy Introduction
7.9.4 CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2020-2025)
7.9.5 CorestemChemon Inc. Recent Development
7.10 ANTEROGEN.CO., LTD.
7.10.1 ANTEROGEN.CO., LTD. Company Details
7.10.2 ANTEROGEN.CO., LTD. Business Overview
7.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Introduction
7.10.4 ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2020-2025)
7.10.5 ANTEROGEN.CO., LTD. Recent Development
7.11 Holostem
7.11.1 Holostem Company Details
7.11.2 Holostem Business Overview
7.11.3 Holostem Stem Cell Therapy Introduction
7.11.4 Holostem Revenue in Stem Cell Therapy Business (2020-2025)
7.11.5 Holostem Recent Development
7.12 NuVasive
7.12.1 NuVasive Company Details
7.12.2 NuVasive Business Overview
7.12.3 NuVasive Stem Cell Therapy Introduction
7.12.4 NuVasive Revenue in Stem Cell Therapy Business (2020-2025)
7.12.5 NuVasive Recent Development
7.13 JCR Pharmaceutical
7.13.1 JCR Pharmaceutical Company Details
7.13.2 JCR Pharmaceutical Business Overview
7.13.3 JCR Pharmaceutical Stem Cell Therapy Introduction
7.13.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2020-2025)
7.13.5 JCR Pharmaceutical Recent Development
7.14 Pharmicell
7.14.1 Pharmicell Company Details
7.14.2 Pharmicell Business Overview
7.14.3 Pharmicell Stem Cell Therapy Introduction
7.14.4 Pharmicell Revenue in Stem Cell Therapy Business (2020-2025)
7.14.5 Pharmicell Recent Development
7.15 Medi-post
7.15.1 Medi-post Company Details
7.15.2 Medi-post Business Overview
7.15.3 Medi-post Stem Cell Therapy Introduction
7.15.4 Medi-post Revenue in Stem Cell Therapy Business (2020-2025)
7.15.5 Medi-post Recent Development
7.16 Anterogen
7.16.1 Anterogen Company Details
7.16.2 Anterogen Business Overview
7.16.3 Anterogen Stem Cell Therapy Introduction
7.16.4 Anterogen Revenue in Stem Cell Therapy Business (2020-2025)
7.16.5 Anterogen Recent Development
7.17 Takeda (TiGenix)
7.17.1 Takeda (TiGenix) Company Details
7.17.2 Takeda (TiGenix) Business Overview
7.17.3 Takeda (TiGenix) Stem Cell Therapy Introduction
7.17.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2020-2025)
7.17.5 Takeda (TiGenix) Recent Development
8 Stem Cell Therapy Market Dynamics
8.1 Stem Cell Therapy Industry Trends
8.2 Stem Cell Therapy Market Drivers
8.3 Stem Cell Therapy Market Challenges
8.4 Stem Cell Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Stem Cell Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Stem Cell Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Stem Cell Therapy Revenue Share by Region (2020-2025)
Table 6. Global Stem Cell Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Stem Cell Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Stem Cell Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Stem Cell Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Stem Cell Therapy Application
Table 18. Global Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Stem Cell Therapy Market Share by Players (2020-2025)
Table 20. Global Top Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
Table 21. Ranking of Global Top Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Stem Cell Therapy, Headquarters and Area Served
Table 24. Global Key Players of Stem Cell Therapy, Product and Application
Table 25. Global Key Players of Stem Cell Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 37. China Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 41. Japan Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Stem Cell Therapy Revenue Market Share by Company (2020-2025)
Table 49. India Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 51. Medipost Company Details
Table 52. Medipost Business Overview
Table 53. Medipost Stem Cell Therapy Product
Table 54. Medipost Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Medipost Recent Development
Table 56. Theracell Advanced Biotechnology Company Details
Table 57. Theracell Advanced Biotechnology Business Overview
Table 58. Theracell Advanced Biotechnology Stem Cell Therapy Product
Table 59. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Theracell Advanced Biotechnology Recent Development
Table 61. Nature Cell Company Details
Table 62. Nature Cell Business Overview
Table 63. Nature Cell Stem Cell Therapy Product
Table 64. Nature Cell Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Nature Cell Recent Development
Table 66. Stempeutics Company Details
Table 67. Stempeutics Business Overview
Table 68. Stempeutics Stem Cell Therapy Product
Table 69. Stempeutics Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Stempeutics Recent Development
Table 71. Regeneus Company Details
Table 72. Regeneus Business Overview
Table 73. Regeneus Stem Cell Therapy Product
Table 74. Regeneus Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Regeneus Recent Development
Table 76. Bluebird bio, Inc Company Details
Table 77. Bluebird bio, Inc Business Overview
Table 78. Bluebird bio, Inc Stem Cell Therapy Product
Table 79. Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Bluebird bio, Inc Recent Development
Table 81. NIPRO Company Details
Table 82. NIPRO Business Overview
Table 83. NIPRO Stem Cell Therapy Product
Table 84. NIPRO Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. NIPRO Recent Development
Table 86. Kyowa Kirin Company Details
Table 87. Kyowa Kirin Business Overview
Table 88. Kyowa Kirin Stem Cell Therapy Product
Table 89. Kyowa Kirin Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Kyowa Kirin Recent Development
Table 91. CorestemChemon Inc. Company Details
Table 92. CorestemChemon Inc. Business Overview
Table 93. CorestemChemon Inc. Stem Cell Therapy Product
Table 94. CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. CorestemChemon Inc. Recent Development
Table 96. ANTEROGEN.CO., LTD. Company Details
Table 97. ANTEROGEN.CO., LTD. Business Overview
Table 98. ANTEROGEN.CO., LTD. Stem Cell Therapy Product
Table 99. ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. ANTEROGEN.CO., LTD. Recent Development
Table 101. Holostem Company Details
Table 102. Holostem Business Overview
Table 103. Holostem Stem Cell Therapy Product
Table 104. Holostem Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 105. Holostem Recent Development
Table 106. NuVasive Company Details
Table 107. NuVasive Business Overview
Table 108. NuVasive Stem Cell Therapy Product
Table 109. NuVasive Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 110. NuVasive Recent Development
Table 111. JCR Pharmaceutical Company Details
Table 112. JCR Pharmaceutical Business Overview
Table 113. JCR Pharmaceutical Stem Cell Therapy Product
Table 114. JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 115. JCR Pharmaceutical Recent Development
Table 116. Pharmicell Company Details
Table 117. Pharmicell Business Overview
Table 118. Pharmicell Stem Cell Therapy Product
Table 119. Pharmicell Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 120. Pharmicell Recent Development
Table 121. Medi-post Company Details
Table 122. Medi-post Business Overview
Table 123. Medi-post Stem Cell Therapy Product
Table 124. Medi-post Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 125. Medi-post Recent Development
Table 126. Anterogen Company Details
Table 127. Anterogen Business Overview
Table 128. Anterogen Stem Cell Therapy Product
Table 129. Anterogen Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 130. Anterogen Recent Development
Table 131. Takeda (TiGenix) Company Details
Table 132. Takeda (TiGenix) Business Overview
Table 133. Takeda (TiGenix) Stem Cell Therapy Product
Table 134. Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 135. Takeda (TiGenix) Recent Development
Table 136. Stem Cell Therapy Market Trends
Table 137. Stem Cell Therapy Market Drivers
Table 138. Stem Cell Therapy Market Challenges
Table 139. Stem Cell Therapy Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cell Therapy Product Picture
Figure 2. Global Stem Cell Therapy Market Share by Type: 2024 VS 2031
Figure 3. Allogeneic Stem Cell Therapies Features
Figure 4. Autologous Stem Cell Therapies Features
Figure 5. Global Stem Cell Therapy Market Share by Application: 2024 VS 2031
Figure 6. Neurodegenerative Diseases
Figure 7. Cardiovascular Disorders
Figure 8. Autoimmune Conditions
Figure 9. Orthopedic Injuries
Figure 10. Cancer
Figure 11. Others
Figure 12. Stem Cell Therapy Report Years Considered
Figure 13. Global Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Stem Cell Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Southeast Asia Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. India Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Central & South America Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global Stem Cell Therapy Market Share by Players in 2024
Figure 24. Global Top Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Stem Cell Therapy Revenue in 2024
Figure 26. North America Stem Cell Therapy Market Share by Type (2020-2025)
Figure 27. North America Stem Cell Therapy Market Share by Application (2020-2025)
Figure 28. Europe Stem Cell Therapy Market Share by Type (2020-2025)
Figure 29. Europe Stem Cell Therapy Market Share by Application (2020-2025)
Figure 30. China Stem Cell Therapy Market Share by Type (2020-2025)
Figure 31. China Stem Cell Therapy Market Share by Application (2020-2025)
Figure 32. Japan Stem Cell Therapy Market Share by Type (2020-2025)
Figure 33. Japan Stem Cell Therapy Market Share by Application (2020-2025)
Figure 34. Southeast Asia Stem Cell Therapy Market Share by Type (2020-2025)
Figure 35. Southeast Asia Stem Cell Therapy Market Share by Application (2020-2025)
Figure 36. India Stem Cell Therapy Market Share by Type (2020-2025)
Figure 37. India Stem Cell Therapy Market Share by Application (2020-2025)
Figure 38. Medipost Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 39. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 40. Nature Cell Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 41. Stempeutics Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 42. Regeneus Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 43. Bluebird bio, Inc Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 44. NIPRO Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 45. Kyowa Kirin Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 46. CorestemChemon Inc. Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 47. ANTEROGEN.CO., LTD. Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 48. Holostem Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 49. NuVasive Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 50. JCR Pharmaceutical Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 51. Pharmicell Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 52. Medi-post Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 53. Anterogen Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 54. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 19.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Stem Cell Therapy in 2031?
What is the annual compound growth rate of the global Stem Cell Therapy market size from 2025 to 2031?
Which companies rank high in the global Stem Cell Therapy market?
What was the global market size of Stem Cell Therapy in 2025?
Related Reports
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stem Cell Therapy market size was US$ 807 million in 2025 and is forecast to reach a readjusted size of US$ 2793 million by 2032 with a CAGR of 19.7% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 105
USD 4250.00
(Single User License)
Global Stem Cell Therapy Market Research Report 2026
The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 139
USD 2900.00
(Single User License)
Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Stem Cell Therapy was estimated to be worth US$ 807 million in 2025 and is projected to reach US$ 2793 million, growing at a CAGR of 19.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 131
USD 3950.00
(Single User License)
Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 123
USD 3950.00
(Single User License)
Global Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stem Cell Therapy market is projected to grow from US$ 685 million in 2024 to US$ 2373 million by 2031, at a CAGR of 19.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 149
USD 4900.00
(Single User License)
Global Stem Cell Therapy Market Research Report 2025
The global market for Stem Cell Therapy was valued at US$ 685 million in the year 2024 and is projected to reach a revised size of US$ 2373 million by 2031, growing at a CAGR of 19.7% during the forecast period.
Published Date: 2025-09-08
Pages: 99
USD 2900.00
(Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 130
USD 5900.00
(Single User License)
Stem Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 93
USD 3950.00
(Single User License)
Global Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published Date: 2024-04-17
Pages: 140
USD 5600.00
(Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published Date: 2024-04-16
Pages: 122
USD 5900.00
(Single User License)
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stem Cell Therapy market size was US$ 807 million in 2025 and is forecast to reach a readjusted size of US$ 2793 million by 2032 with a CAGR of 19.7% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 105
USD 4250.00 (Single User License)Global Stem Cell Therapy Market Research Report 2026
The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 139
USD 2900.00 (Single User License)Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Stem Cell Therapy was estimated to be worth US$ 807 million in 2025 and is projected to reach US$ 2793 million, growing at a CAGR of 19.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 131
USD 3950.00 (Single User License)Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 123
USD 3950.00 (Single User License)Global Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stem Cell Therapy market is projected to grow from US$ 685 million in 2024 to US$ 2373 million by 2031, at a CAGR of 19.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 149
USD 4900.00 (Single User License)Global Stem Cell Therapy Market Research Report 2025
The global market for Stem Cell Therapy was valued at US$ 685 million in the year 2024 and is projected to reach a revised size of US$ 2373 million by 2031, growing at a CAGR of 19.7% during the forecast period.
Published: 2025-09-08
Pages: 99
USD 2900.00 (Single User License)Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 130
USD 5900.00 (Single User License)Stem Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 93
USD 3950.00 (Single User License)Global Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published: 2024-04-17
Pages: 140
USD 5600.00 (Single User License)Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published: 2024-04-16
Pages: 122
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now